UK markets open in 7 hours 5 minutes

Puma Biotechnology, Inc. (PBYI)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
9.90+0.18 (+1.85%)
At close: 4:00PM EDT
9.90 0.00 (0.00%)
After hours: 04:55PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2020
31/12/2019
31/12/2018
31/12/2017
Total revenue
272,062
225,110
272,260
250,991
27,685
Cost of revenue
59,855
39,374
36,815
34,621
5,572
Gross profit
212,207
185,736
235,445
216,370
22,113
Operating expenses
Research development
92,423
97,650
132,851
164,854
207,810
Selling general and administrative
115,789
118,488
140,509
146,188
106,693
Total operating expenses
208,212
216,138
273,360
311,042
314,503
Operating income or loss
3,995
-30,402
-37,915
-94,672
-292,390
Interest expense
14,428
14,046
15,019
10,985
720
Total other income/expenses net
-
-15,829
-25,508
-9,714
-101
Income before tax
-26,289
-59,788
-75,595
-113,575
-291,955
Income tax expense
245
207
-
-
-
Income from continuing operations
-26,534
-59,995
-75,595
-113,575
-291,955
Net income
-26,534
-59,995
-75,595
-113,575
-291,955
Net income available to common shareholders
-26,534
-59,995
-75,595
-113,575
-291,955
Basic EPS
-
-1.52
-1.95
-2.99
-7.85
Diluted EPS
-
-1.52
-1.95
-2.99
-7.85
Basic average shares
-
39,576
38,769
37,942
37,170
Diluted average shares
-
39,576
38,769
37,942
37,170
EBITDA
-
-35,709
-52,499
-95,206
-288,424